Effect of bioflavonoid quercetin on the course of inflammatory process in herpetic keratitis patients with dry eye syndrome
DOI:
https://doi.org/10.31288/oftalmolzh201631921Keywords:
herpetic keratitis, dry eye syndrome, cornea, clinical signs, LipoflavonAbstract
Backup: The problem of dry eye syndrome is of great importance and significance in ophthalmology.
The purpose of the present paper was to study the effect of Lipoflavon on the course of inflammatory process in herpetic keratitis (HK ) patients with dry eye syndrome (DES).
Material and Methods: Clinical study was performed in 40 patients with HK (superficial dendritic keratitis) and DES; additionally, we followed up 17 patients with HK. All patients were divided into two groups: Study Group included 15 HK and DES patients receiving Lipoflavon treatment; Control Group included 25 HK and DES patients receiving traditional treatment. The state of the cornea was scored by Draize criteria. The data obtained were statistically processed using SPSS 11.0 package.
Results: Assessing the data obtained in the present study, it is arguable that Lipoflavon significantly decreases clinical signs in patients with HK and DES.
Conclusions: Inclusion of Lipoflavon in the complex treatment of HK patients with DES significantly increases the efficacy of therapy that is evidenced by the fact that corneal epithelization and infiltrate dispersion are accelerated, and corneal edema and epitheliopathy of the cornea and conjunctiva are less apparent after treatment of patients in Study group as compared to control. The use of quercetin has a positive effect on qualitative and quantitative characteristics of tear production in patients with HK and DES, in particular, Schirmer test values are increased, tear break-up time is increased, conjunctival fold intensity is decreased and tear meniscus height is increased.
References
Wilson SE, Netto M, Ambrosio R. Corneal cells: chatty in development, homeoatasis, wound healing, and disease. Am. J. Ophthalmol. 2003; 136: 530-6.https://doi.org/10.1016/S0002-9394(03)00085-0
Skripnik RL, Skripnichenko ID. New development in the treatment of dry eye syndrome. Ukr. Med. Chasopys. 2011;1(81):79-80. Russian.
Bourcier T, Borderie V. Decreased corneal sensitivity in patients with dry eye. Invest. Ophthalmol. Vis. Sci. 2005;46:2341-5.https://doi.org/10.1167/iovs.04-1426
Brzheskii VV. [Tactics of medicamental treatment of patients with various clinical forms of dry eye syndrome]. Klinicheskaia oftalmologiia. 2008;1:4-6. Russian.
Drozhzhina GI. [Modern methods of treatment of the dry eye syndrome]. Oftalmol Zh.2013;5;89-95. Russian.
Baudouin C. The pathology of dry eye. Surv. Ophthalmol. 2001; 45: S211-S220.
Begley CG, Chalmers RL, Abetz L. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest. Ophthalmol. Vis. Sci. 2003;44:4753-61.
Javadi MA, Feizi S. Dry Eye Syndrome. J. Ophthalmic. Vis. Res. 2011;6:192-8.
Gaydamaka TB, Rafalyuk SYa. [Effect of lipoflavon on the activity of redox enzymes in the tear fluid in keratitis in patients with dry eye syndrome]. Ophthalmology. 2016;13(1):4-9. Russian.
Nasledov A. [SPSS computer analysis of data in psychology and social studies]. St.-Petersburg: Piter Publ. 2005:416. Russian.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 С. Я. Рафалюк
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
